-
Mashup Score: 0
Medicare beneficiaries face wide variation in spending for specialty drugs across Part D plans, according to a new analysis.
Source: FierceHealthcareCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 3Annual Out-Of-Pocket Spending Clusters Within Short Time Intervals: Implications For Health Care Affordability | Health Affairs Journal - 4 year(s) ago
The distribution of out-of-pocket spending throughout the year is an important determinant of health care affordability that has received little attention. We used 2017 data from a large database of US commercial insurance claims to study the distribution of patient-level out-of-pocket spending throughout the year, highlighting potential hardship due to temporal clustering of spending. We found…
Source: www.healthaffairs.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
In a NEW considering health spending article from the Feb. issue, @chenssteve of @EmoryUniversity et al. analyze the distribution of #OutOfPocket spending throughout the year to draw insights about the implications for health care affordability. Read here: https://t.co/iuHyn5SKV8 https://t.co/geBMwNY6CC
-
-
Mashup Score: 3
OP expenses may influence treatment decisions, delay care, and cause financial burden for patients. Methods: We conducted a retrospective cohort study of patients with employer-sponsored insurance undergoing common outpatient surgical procedures (cholecystectomy, cataract surgery, meniscectomy, muscle/tendon procedures, and joint procedures) from 2011 to 2017. Total payments for surgical…
Source: LWWCategories: Latest Headlines, SurgeryTweet-
A detailed look at recent trends in elective surgery costs for our patients & the system by insurance design, operative setting, and geography. @BilligJessica @ErikaDSears @kecchung https://t.co/xZY10ovDYs @UMichSurgery @UM_IHPI @ncspMICHIGAN @VA_CCMR #healthcarecost #outofpocket https://t.co/v1yICXKKfM
-
.@GoodRx - #Outofpocket costs can vary widely for #specialty drugs in Part D | #pharma https://t.co/PsRUaxjOPK